Scholarlink

<p>Patients with type 2 diabetes (T2D) frequently have increased cardiovascular (CV) risk, yet real-world control of guideline-recommended cardiometabolic risk factors remains suboptimal. We quantified the proportion of Romanian adults with T2D who were at recommended targets for key CV risk factors across ESC CV risk categories. In this single-center cross-sectional study, we recorded HbA1c, LDL-cholesterol (LDL-c), triglycerides and blood pressure (BP). Targets were defined using contemporary guideline recommendations (HbA1c &lt;7.0%, BP &lt;130/80 mmHg, triglycerides &lt;150 mg/dL, and risk-category-specific LDL-c targets). BMI was reported descriptively and was not considered treatment target. We included 174 patients (median age 61 years; 50% women); 81.6% were at very high and 14.4% at high CV risk. Overall, 46.6% were at the HbA1c target, 20.1% at the LDL-c target, 58.0% at the triglyceride target, and 42.0% at the BP target. Across ESC risk categories, control of individual targets was consistently limited, with particularly low proportions at LDL-c target. In this real-world Romanian T2D cohort, a minority of patients were at recommended targets for major CV risk factors, especially LDL-c, underscoring the need for systematic, risk-based intensification of cardiometabolic management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cardiovascular risk factor target control in Romanian adults with type 2 diabetes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月31日

查看全文
  • Silvia Ana Luca,
  • Raluca Malina Bungau,
  • Andreea Herascu,
  • Vlad Florian Avram,
  • Sandra Lazar,
  • Bogdan Timar

摘要

Patients with type 2 diabetes (T2D) frequently have increased cardiovascular (CV) risk, yet real-world control of guideline-recommended cardiometabolic risk factors remains suboptimal. We quantified the proportion of Romanian adults with T2D who were at recommended targets for key CV risk factors across ESC CV risk categories. In this single-center cross-sectional study, we recorded HbA1c, LDL-cholesterol (LDL-c), triglycerides and blood pressure (BP). Targets were defined using contemporary guideline recommendations (HbA1c <7.0%, BP <130/80 mmHg, triglycerides <150 mg/dL, and risk-category-specific LDL-c targets). BMI was reported descriptively and was not considered treatment target. We included 174 patients (median age 61 years; 50% women); 81.6% were at very high and 14.4% at high CV risk. Overall, 46.6% were at the HbA1c target, 20.1% at the LDL-c target, 58.0% at the triglyceride target, and 42.0% at the BP target. Across ESC risk categories, control of individual targets was consistently limited, with particularly low proportions at LDL-c target. In this real-world Romanian T2D cohort, a minority of patients were at recommended targets for major CV risk factors, especially LDL-c, underscoring the need for systematic, risk-based intensification of cardiometabolic management.